Abstract:Background and aim of the study: The study aim was to evaluate the effect of percutaneous balloon mitral valvuloplasty (PBMV) on plasma B-type natriuretic peptide (BNP) levels in patients in sinus rhythm (SR) and with atrial fibrillation (AF).Methods: Thirty patients with rheumatic mitral stenosis who underwent successful PBMV were included in the study. Of these patents, 21 were in SR (SR group) and nine had AF (AF group). Plasma BNP levels were measured using the Triage BNP Test in all patients before, and at 20 min and 24 h after, PBMV. Control levels were measured in eight healthy volunteers.Results: Basal plasma BNP levels in patients were significantly higher than those in controls (123.5 +/- 69.5 versus 16.4 +/- 7.6 pg/ml, p < 0.01), and correlated with mean left atrial pressure (mLAP; r = 0.441, p < 0.05) and pulmonary artery pressure (PAP; r = 0.488, p < 0.01). No significant difference was observed in BNP levels between the SR and AF groups. In the SR group, BNP levels decreased after PBMV (pre-PBMV 128.7 +/- 75.9 pg/ml; at 20 min, 88.6 +/- 62.0 pg/ml; at 24 h, 43.4 +/- 26.7 pg/ml; respectively, p < 0.05). Changes in plasma BNP (Delta BNP) correlated positively with those in mLAP (Delta mLAP) (r = 0.696, p < 0.01) and PAP (APAP) (r = 0.456, p < 0.05). Left ventricular end-diastolic volume (LVEDV) (96.1 +/- 21.6 versus 111.5 +/- 25.2 ml, p < 0.01) and stroke volume (SV) (59.2 +/- 15.8 versus 69.0 +/- 17.9 ml, p < 0.05) augmented accordingly without any changes in left ventricular end-diastolic pressure (LVEDP) (p = NS). In contrast, in group AF, BNP levels remained unchanged (pre-PBMV 111.6 +/- 53.4 pg/ml; at 20 min, 122.0 +/- 68.7 pg/ml; at 24 h, 106.1 +/- 56.2 pg/ml; respectively, p NS), while LVEDP increased (6.4 +/- 3.6 versus 8.6 +/- 3.2 mmHg, p < 0.01), without any changes in LVEDV and SV (p = NS).Conclusion: The study results indicate that, in mitral stenosis patients, a high BNP level is associated with high mLAP and PAP. Cardiac rhythm may play an important role in changes of BNP level after PBMV. BNP may be a valid marker to reflect changes in mLAP and PAP after PBMV in patients with SR, but not in those with AF.

Changes of Plasma B-type Natriuretic Peptide after Percutanouse Balloon Mitral Valvuloplasty

Effects of Percutaneous Balloon Mitrai Valvuloplasty on Plasma B-type Natriuretic Peptide in Rheumatic Mitral Stenosis Patients

Effects of Percutaneous Balloon Mitral Valvuloplasty on Plasma B-type Natriuretic Peptide in Rheumatic Mitral Stenosis with and Without Atrial Fibrillation.

Clinical Effect of Percutaneous Balloon Mitral Valvuloplasty in Treatment of Rheumatic Mitral Stenosis

Assessment of Left Atrial Strain in Patients Pre-and Post-Mitral Valvuloplasty by Using Two-Dimensional Speckle Tracking Echocardiography

BNP levels and its influencing factors in patients with acute coronary syndrome

Clinical application of percutaneous balloon mitral valvuloplasty in patients with rheumatic mitral stenosis and left atrial thrombi

The Correlation Of Left Ventricular Remodeling And Plasma Brain Natriuretic Peptide Undergoing Different Reperfusion In Patients With First ST-segment Elevation Acute Anterior Myocardial Infarction 1

Relationship between the extent of coronary artery lesions and plasma brain natriuretic peptide

Left Ventricular Geometry and the Levels of Plasma B-type Natriuretic Peptide and Serum Procollagen TypeⅢ in Essential Hypertensive Patients

Use of B-type Natriuretic Peptide in Evaluation of Early Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome.

Clinical significance and changes of plasma brain natriuretic peptide level in patients with chronic obstructive pul monary disease under different conditions

Changes in Brain Natriuretic Peptide Are Correlated with Changes in Global End-Diastolic Volume Index

Evaluation on Results of Repeat Percutaneous Balloon Mitral Valvuloplasty for Mitral Restenosis Following Prior Balloon Valvuloplasty

Assessment of function on left atrial and biventricular in patients with rheumatic mitral stenosis before and after percutaneous mitral balloon valvuloplasty by real-time three-dimensional echocardiography

B-type Natriuretic Peptides for Prediction of Weaning Failure from Mechanical Ventilation after Off-Pump Coronary Artery Bypass Grafting

Short Term and Long-Term Results of Percutaneous Balloon Mitral Valvuloplasty in Patients with Mitral Stenosis and Atrial Fibrillation

Plasma Brain Natriuretic Peptide Levels in the Diagnosis of Heart Failure

Assessment of B-Natriuretic Peptide Levels After Stage 1 Palliation in Hypoplastic Left Heart Syndrome Patients

Recombinant Human B-type Natriuretic Peptides in Cardiac Surgical Procedures

Prognosis Value of Sequential B-type Natriuretic Peptide Measurements for Patients Hospitalized with Chronic Congestive Heart Failure